Screening for endometrial cancer

Medical Journal of Australia

Volumn 178, Issue 12, 2003, Pages 657-659

  Robertson, Gregory ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN DERIVATIVE; HORMONE; TAMOXIFEN;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLON CANCER; DRUG INDUCED CANCER; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FAMILY COUNSELING; FEMALE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; PAPANICOLAOU TEST; PATIENT EDUCATION; POSTMENOPAUSE; REVIEW; RISK FACTOR; SPOTTING; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING;

EID: 0038166709     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05400.x     Document Type: Review

References (11)

1. Australian Institute of Health and Welfare and the Australian Association of Cancer Registries. Cancer in Australia 1999. Canberra: AIHW and Australian Association of Cancer Registries, 2002.
2. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary non-polyposis colo-rectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-1027.
3. Gerber B, Krause A, Muller H, et al. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. Eur J Cancer 2001; 37: 64-71.
4. Langer RD, Pierce JJ, O'Hanlan KA, et al. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease: Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med 1997; 337: 1792-1798.
5. Fleischer AC, Wheeler JE, Lindsay I, et al. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001; 184: 70-75.
6. Ferrazzi E, Torri V, Trio D, et al. Sonographic endometrial thickness: A useful test to predict atrophy in patients with postmenopausal bleeding. Ultrasound Obstet Gynecol 1996; 7: 315-321.
7. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - A Nordic multicenter study. Am J Obstet Gynecol 1995; 172: 1488-1494.
8. Gerber B, Krause A, Muller H, et al. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: A prospective long-term study using transvaginal ultrasound. J Clin Oncol 1994; 18: 3464-3470.
9. Royal Australian College of Obstetrics and Gynaecology. From the working party on tamoxifen and the endometrium. RACOG Bulletin 1996; 10(1).
10. Ng ABP, Reagan JW, Hawliczek CT, Wentz BW. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol 1974; 18: 356-361.
11. Gusberg SB, Milano C. Detection of endometrial carcinoma and its precursors. Cancer 1981; 47: 1173-1179.